15 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941428/0/en/Scilex-Holding-Company-Announces-Acceptance-of-Presentation-at-the-2024-American-College-of-Rheumatology-Convergence-Conference-to-be-held-at-the-Walter-E-Washington-Convention-Cen.html
14 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/14/2881481/0/en/Scilex-Holding-Company-Announces-Final-Court-Approval-of-a-Settlement-Agreement-with-Takeda-Pharmaceuticals-to-Resolve-the-Paragraph-IV-Patent-Infringement-Lawsuit-Relating-to-Scil.html
30 Apr 2024
// PRESS RELEASE
https://granulesindia.com/wp-content/uploads/2024/04/Granules-India-Limited-Announced-ANDA-Approval-for-Colchicine-Capsules.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215762
19 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/19/2798587/0/en/Scilex-Holding-Company-Announces-Results-from-Market-Research-with-Rheumatologists-Reveal-a-High-Degree-of-Interest-in-Gloperba-as-a-Liquid-Colchicine-Formulation-Designed-for-Prec.html